Table 4 Variant titer fold changes from WT (614D/G) per serum group (conv = convalescent). Mean fold drops were calculated from fold drops per study, not from GMT fold drops. Studies reporting fold drops but not GMTs result in a discrepancy between GMT based mean fold drop and individual study based mean fold drop (Table 2). The 95% CI is given in parentheses, the number of data points n in the next line. WT summarizes wild type-like strains (e.g: 614D, 614G).
Serum Group | Alpha | Beta | Gamma | Delta |
|---|---|---|---|---|
2x Vax | 1.3 (1; 1.7) | 4.6 (3.8; 5.5) | 2.6 (1.6; 4.2) | 2.7 (2.3; 3.3) |
n=11 | n=44 | n=7 | n=50 | |
3x Vax | 1 (0.7; 1.4) | 2.6 (2.1; 3.3) | 2.3 (1.9; 2.6) | |
n=9 | n=30 | n=33 | ||
Inf + Vax | 1.7 | 3.1 (2.2; 4.2) | 3.3 | 1.8 (1.2; 2.8) |
n=1 | n=12 | n=1 | n=16 | |
Vax + Inf | 1.2 (0; 504.7) | 5 (1.3; 18.9) | 3.2 | 1.9 (1.2; 2.9) |
n=2 | n=3 | n=1 | n=10 | |
Vax + BA.1 | 1.1 (0.5; 2.3) | 2.2 (1.4; 3.7) | 1.8 (1.3; 2.5) | |
n=5 | n=10 | n=15 | ||
Vax + BA.2 | 0.7 (0.7; 0.7) | 1.7 (1.7; 1.7) | 2.1 (0.1; 30) | |
n=2 | n=2 | n=3 | ||
WT conv | 2.1 (1.5; 3) | 6.1 (3.7; 10) | 3.5 (1.2; 10.1) | 2.2 (1.7; 2.8) |
n=7 | n=9 | n=4 | n=18 | |
Alpha conv | 0.6 (0.3; 1) | 2.7 (1; 7.4) | 2.6 (0.4; 15.4) | 1.8 (1.2; 2.8) |
n=7 | n=6 | n=4 | n=8 | |
Beta conv | 0.8 (0.3; 2.3) | 0.3 (0.2; 0.8) | 0.4 (0.1; 3.2) | 1.5 (0.6; 3.9) |
n=5 | n=5 | n=4 | n=6 | |
Gamma conv | 0.9 (0.5; 1.6) | 0.6 (0.3; 1.2) | 0.3 (0.1; 0.9) | 2.6 (0.9; 7.6) |
n=4 | n=4 | n=3 | n=4 | |
Delta conv | 1.1 (0.7; 1.7) | 2.7 (1.4; 5) | 1.6 (0.3; 7.8) | 0.2 (0.1; 0.3) |
n=6 | n=6 | n=4 | n=10 | |
BA.1 conv | 1.7 (1.1; 2.5) | 1.5 (0.8; 2.7) | 1 (0; 70) | 1.1 (0.8; 1.7) |
n=4 | n=7 | n=2 | n=9 | |
BA.2 conv | 1.1 | 1.1 | 2.4 | 0.7 (0; 45.1) |
n=1 | n=1 | n=1 | n=2 |